Lamar Health vs IBM
Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare startup navigating prior authorization appeals for expensive medication coverage; $900K revenue bootstrapped helping patients get insurance approvals for specialty drugs.
About
Lamar Health is a healthcare technology company that navigates the prior authorization and insurance appeals process on behalf of patients who need coverage for expensive medications — particularly specialty drugs (biologics, brand-name medications for rare conditions) where insurers frequently deny coverage initially, requiring systematic appeals to achieve approval. Founded and a Y Combinator W21 graduate, Lamar Health raised $125,000 from YC and Plug and Play Tech Center, achieving $900,000 in revenue in 2024 with a 6-person team through largely bootstrapped operations.\n\nLamar Health's service works by handling the complex administrative and clinical documentation process that prior authorization and insurance appeals require. When a doctor prescribes a medication that the patient's insurance denies, Lamar's team prepares the clinical justification, compiles supporting medical documentation, and submits appeals — iterating through insurer-specific appeal processes (first-level appeal, peer-to-peer review, external review) until coverage is approved or options are exhausted. This process can take weeks to months and requires specialized knowledge of each insurer's appeal procedures.\n\nIn 2025, Lamar Health operates in the prior authorization management market alongside CoverMyMeds (McKesson), RxBenefits, and health system-level revenue cycle management vendors for medication access and prior authorization automation. Prior authorization has become one of the most significant friction points in US healthcare — the American Medical Association reports that the volume of prior authorizations has increased dramatically, with physicians spending significant time on administrative appeals rather than patient care. Lamar's patient-focused approach (working on behalf of patients, not providers or plans) addresses the most vulnerable point in the access breakdown. The 2025 strategy focuses on scaling the service through employer benefits channel partnerships and developing AI-powered tools to accelerate the appeals documentation process.
Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.
About
International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.